Skip to main content

Table 7 Outcome for biological markers: immunological

From: The clinical use of biomarkers as prognostic factors in Ewing sarcoma

Author

Year

Biomarker

Pt number

P

Rutkowski et al, J Surg Oncol 84, 151-9[27]

2003

IL-1ra

13

0.0001

Rutkowski et al, J Surg Oncol 84, 151-9[27]

2003

sIL-2ra

13

0.005

Rutkowski et al, J Surg Oncol 84, 151-9[27]

2003

IL-6

13

0.001

Rutkowski et al, J Surg Oncol 84, 151-9[27]

2003

IL-8

13

0.0001

Rutkowski et al, J Surg Oncol 84, 151-9[27]

2003

IL-10

13

0.01

Rutkowski et al, J Surg Oncol 84, 151-9[27]

2003

TNF RI

13

0.001

Rutkowski et al, J Surg Oncol 84, 151-9[27]

2003

TNF RII

13

0.01

Rutkowski et al, J Surg Oncol 84, 151-9[27]

2003

M-CSF

13

0.01

Berghuis et al, J Pathol 218, 222-31[66]

2009

HLA class I

67

NS

  1. NS: not significant